What is the recommended workup and acute management for a suspected cardiac cause in a patient presenting with tachycardia?

Workup and Acute Management of Cardiac-Cause Tachycardia

For suspected cardiac tachycardia, immediately obtain a 12-lead ECG to classify the rhythm by regularity and QRS width, then treat hemodynamically unstable patients with synchronized cardioversion (200J for atrial fibrillation, 50-100J for monomorphic VT), while stable patients receive rhythm-specific pharmacotherapy guided by QRS morphology. 1, 2

Initial Diagnostic Approach

The cornerstone of cardiac tachycardia evaluation is immediate 12-lead ECG documentation to classify the arrhythmia using two critical variables 3:

• Regularity of rhythm (regular vs. irregular)
• QRS width (narrow <0.12s vs. wide ≥0.12s)

This classification drives your entire management algorithm and allows differentiation in >90% of cases 4.

Essential Concurrent Workup

While obtaining the ECG, simultaneously assess 5:

• Vital signs: Heart rate, blood pressure, oxygen saturation (measure frequently until stabilized)
• Precipitating factors: Medication/dietary noncompliance, infection, pulmonary embolism, acute coronary syndrome, electrolyte abnormalities
• Chest x-ray within 1-2 hours to evaluate cardiac size, pulmonary congestion
• Laboratory tests: Serum electrolytes, renal function, troponin (if ischemic symptoms present)
• Echocardiography: Essential for evaluating LV/RV function, valvular disease, wall motion abnormalities

Critical pitfall: Troponin elevation occurs in 30-50% of SVT cases due to supply-demand mismatch, not plaque rupture—avoid reflexive cardiac catheterization unless ischemic ECG changes or high-risk features present 6.

Acute Management Algorithm

Hemodynamically Unstable Patients (ANY Tachycardia)

Immediate synchronized cardioversion is the definitive treatment 1, 7:

• Atrial fibrillation: 200J monophasic shock
• Atrial flutter: 50J
• Monomorphic VT >150 bpm: 100J synchronized
• Polymorphic VT: 200J unsynchronized (treat as VF)

Precede with brief general anesthesia or conscious sedation when possible 8.

Hemodynamically Stable Patients: Narrow-Complex Regular Tachycardia

First-line approach 2, 1:

1. Vagal maneuvers (carotid massage, Valsalva)
2. Adenosine 6mg IV rapid push over 1-2 seconds
   • If no response: 12mg after 1-2 minutes
   • Repeat 12mg if needed
   • Advantages: Rapid onset, short half-life, preferred except in severe asthma
   • Cautions: May trigger transient AF (1-15%), potentiated by dipyridamole, antagonized by theophylline

Second-line options if adenosine fails 9, 2:

• IV beta-blockers: Metoprolol 2.5-5mg every 2-5 minutes (total 15mg over 10-15 minutes)
• IV diltiazem: 20mg (0.25mg/kg) over 2 minutes, then 10mg/h infusion
• IV verapamil: Similar dosing to diltiazem

Important downgrade: The 2019 ESC guidelines downgraded verapamil/diltiazem from Class I to lower recommendations for narrow-complex tachycardias, with adenosine and beta-blockers now preferred 10.

Hemodynamically Stable Patients: Wide-Complex Regular Tachycardia

Assume ventricular tachycardia until proven otherwise 1, 7.

For monomorphic VT 4:

• Rates <150 bpm: Brief medication trial acceptable
• Rates >150 bpm: Consider immediate cardioversion

Pharmacologic options (in order of preference) 1, 7:

1. IV amiodarone: 150mg over 10 minutes, then 1mg/min × 6 hours, then 0.5mg/min maintenance
2. IV procainamide: 20-30mg/min loading (up to 12-17mg/kg), then 1-4mg/min infusion
3. IV sotalol: May be considered

Amiodarone is preferred over procainamide/sotalol for patients with impaired LV function or heart failure 7.

Critical contraindications 1, 7:

• Never use verapamil or diltiazem for wide-complex tachycardia (Class III harm)
• Avoid adenosine in hemodynamically unstable, irregularly irregular, or polymorphic wide-complex tachycardia

Exception: IV adenosine may be considered for stable, regular, monomorphic wide-complex tachycardia when diagnosis uncertain (aids rhythm diagnosis) 1, 2.

Atrial Fibrillation/Flutter with Rapid Ventricular Response

With hemodynamic compromise or ongoing ischemia 8:

• Synchronized cardioversion (200J for AF, 50J for flutter)
• If recurrent: IV amiodarone or IV digoxin (for severe LV dysfunction/heart failure)

Without hemodynamic compromise but with ongoing ischemia 8:

1. Beta-blockers preferred (unless contraindicated)
2. IV diltiazem or verapamil
3. Synchronized cardioversion if medications fail

Without compromise or ischemia: Rate control with beta-blockers or calcium channel blockers, plus anticoagulation 8.

Specific Cardiac Scenarios

Acute Coronary Syndrome Context

If AHF considered secondary to acute/recent coronary syndrome, coronary angiography should be considered as revascularization improves prognosis 5. However, activation of the cardiac catheterization lab is appropriate for refractory VT even without STEMI 11.

Post-MI Arrhythmias

Bradyarrhythmias 4:

• Symptomatic sinus bradycardia (HR <50 with hypotension/ischemia): Atropine
• Symptomatic AV block at AV nodal level: Atropine
• Infranodal AV block: Atropine contraindicated (Class III)—consider temporary pacing

VT/VF timing matters 4:

• Majority occur within first 48 hours post-MI
• Sustained VT/VF outside this window requires electrophysiology study consideration
• Monomorphic VT <170 bpm suggests chronic substrate, not acute MI

Management Pitfalls to Avoid

1. Don't use calcium channel blockers in acute heart failure with systolic dysfunction (Class III) 5—exception: diltiazem for AF with rapid rate in preserved systolic function

2. Don't routinely give ACE inhibitors in first hours of AHF—introduce when stabilized 5

3. Don't use lidocaine as first-line for stable VT—less effective than amiodarone, procainamide, or sotalol; unclear if better than placebo 1

4. Don't combine antiarrhythmics—may be arrhythmogenic 1

5. Don't use IV calcium channel blockers and beta-blockers together—potentiation of hypotension/bradycardia 7

Ongoing Monitoring

• Continuous cardiac monitoring until stabilized
• Frequent vital signs (HR, BP, O2 saturation)
• Fluid balance monitoring with bladder catheterization if needed 5
• Serial electrolytes/renal function if shock or significant renal dysfunction present (first 24 hours) 5
• Oxygen therapy for all patients with hypoxia; escalate to CPAP/BiPAP/intubation if persistent 5

For refractory cases: Consider intra-aortic balloon pump, and transfer patients in cardiogenic shock with low comorbidity burden to tertiary centers with mechanical circulatory support and transplant capabilities 5.